Getting a standard cholesterol screening may soon involve one more blood test that has been around for decades but is rarely used. Evidence continues to mount showing that the additional analysis can ...

3. C-Reactive Protein (CRP). Patients with obesity and metabolic syndrome have elevated CRP levels, which is a risk factor for coronary heart disease, hypertension, type 2 diabetes and atherogenic ...

We expect investors to focus on updates related to Viking Therapeutics’ VKTX pipeline when it reports first-quarter 2024 results on Apr 24, after market close. In the last reported quarter, the ...

Q1 2024 Earnings Call April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: ...

Additionally, VK2809-treated patients demonstrated statistically significant reductions in low-density lipoprotein cholesterol (LDL-C), triglycerides, and atherogenic lipoproteins, all of which have ...